Activity Overview

Current treatment guidelines recognize the progressive natural history of type 2 diabetes mellitus (T2DM) and the eventual need for insulin therapy while also emphasizing individualized, patient-centered care. Yet widespread hesitation to initiate basal insulin even when its use is clearly indicated has been well documented. The landmark cardiovascular outcomes trials ORIGIN and DEVOTE can help to resolve some long-standing concerns healthcare professionals (HCPs) may have about insulin therapy in T2DM as well as establish new benchmarks for clinical management.

This interactive monograph (eBook) will summarize cardiovascular outcomes data and relevant findings from other clinical trials and observational studies so that all HCPs who manage patients with T2DM can make fully informed, appropriate, and patient-centered decisions about current options in basal insulin therapy.

Enter and explore this online activity